Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
Herrlinger U, Schabet M, Brugger W, Kortmann RD, Küker W, Deckert M, Engel C, Schmeck-Lindenau HJ, Mergenthaler HG, Krauseneck P, Benöhr C, Meisner C, Wiestler OD, Dichgans J, Kanz L, Bamberg M, Weller M. Herrlinger U, et al. Among authors: krauseneck p. Ann Neurol. 2002 Feb;51(2):247-52. doi: 10.1002/ana.10102. Ann Neurol. 2002. PMID: 11835382 Clinical Trial.
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M, Müller B, Koch R, Bamberg M, Krauseneck P; Neuro-Oncology Working Group of the German Cancer Society. Weller M, et al. Among authors: krauseneck p. J Clin Oncol. 2003 Sep 1;21(17):3276-84. doi: 10.1200/JCO.2003.03.509. J Clin Oncol. 2003. PMID: 12947063 Clinical Trial.
Chemotherapy of malignant gliomas.
Krauseneck P, Müller B. Krauseneck P, et al. Recent Results Cancer Res. 1994;135:135-47. doi: 10.1007/978-3-642-85039-4_14. Recent Results Cancer Res. 1994. PMID: 7519355 Review. No abstract available.
27 results